Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138762 · ClinicalTrials.gov registry record · Phase 3
A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,800
- Enrollment target
NCT00138762: Completed Phase 3 study, sponsored by Pfizer.
NCT00138762 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 3,800 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (392% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00138762, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,800 participants
- Enrollment target
Study Summary
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.
Interventions
- DRUG placebo
- DRUG atorvastatin
- DRUG torcetrapib/atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,800 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-08 |
| Phase | Phase 3 |
What the finished NCT00138762 record still lists
NCT00138762 is an interventional study that assigns participants to a tested intervention. Its 3,800 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (392% higher).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00138762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00138762 about?
NCT00138762 is a clinical study titled "A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol". The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.
What is the current status of trial NCT00138762?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,800 participants. The study started on 2004-07. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00138762?
The interventions under investigation include: placebo (DRUG), atorvastatin (DRUG), torcetrapib/atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00138762?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00138762's enrollment target sits among peer trials
3,800 66th of 2000 higher than 1,935 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia